drugset
drugset / Trial / NCT03096327

TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)

NCT03096327 ↗

Phase 4 Completed 180 enrolled PharmEvo Pvt Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

• To compare the quality of Life using AQLQ (s) questionnaire after 4 weeks of Montelukast.

Timeline

Start
2017-05-01
Primary completion
2017-12-30
Completion
2018-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg Oral

Indications

asthma